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Abstract
Bornaviruses, which chronically infect many species, can cause severe neurological diseases in some animal species; their
association with human neuropsychiatric disorders is, however, debatable. The epidemiology of Borna disease virus (BDV),
as for other members of the family Bornaviridae, is largely unknown, although evidence exists for a reservoir in small
mammals, for example bank voles (Myodes glareolus). In addition to the current exogenous infections and despite the fact
that bornaviruses have an RNA genome, bornavirus sequences integrated into the genomes of several vertebrates millions
of years ago. Our hypothesis is that the bank vole, a common wild rodent species in traditional BDV-endemic areas, can
serve as a viral host; we therefore explored whether this species can be infected with BDV, and if so, how the virus spreads
and whether viral RNA is transcribed into DNA in vivo. We infected neonate bank voles intracerebrally with BDV and
euthanized them 2 to 8 weeks post-infection. Specific Ig antibodies were detectable in 41%. Histological evaluation revealed
no significant pathological alterations, but BDV RNA and antigen were detectable in all infected brains. Immunohistology
demonstrated centrifugal spread throughout the nervous tissue, because viral antigen was widespread in peripheral nerves
and ganglia, including the mediastinum, esophagus, and urinary bladder. This was associated with viral shedding in feces, of
which 54% were BDV RNA-positive, and urine at 17%. BDV nucleocapsid gene DNA occurred in 66% of the infected voles,
and, surprisingly, occasionally also phosphoprotein DNA. Thus, intracerebral BDV infection of bank vole led to systemic
infection of the nervous tissue and viral excretion, as well as frequent reverse transcription of the BDV genome, enabling
genomic integration. This first experimental bornavirus infection in wild mammals confirms the recent findings regarding
bornavirus DNA, and suggests that bank voles are capable of bornavirus transmission.
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Introduction
Natural bornavirus infections are associated with chronic
progressive neurological diseases: Borna disease virus (BDV)
causes a classically fatal meningoencephalomyelitis mainly in
horses [1], and avian Bornavirus (ABV) causes proventricular
dilatation disease, which affects the autonomous nervous system in
birds [2]. BDV infection can, however, also remain subclinical or
result in mild neurobehavioral manifestations [1,3]. Especially in
humans, markers of BDV infection have been demonstrated in
several neuropsychiatric diseases [4–6], but although BDV or a
BDV-like agent appears to infect humans [7], the existence of
human Borna disease is still debatable [8–10].
BDV is a neurotropic and noncytolytic RNA virus comprising,
together with ABV, the family Bornaviridae in the order
Mononegavirales. The viral RNA codes for six proteins, including
the nucleo- (N) and phosphoproteins (P) [11,12]. Surprisingly,
since they have an RNA genome and are not retroviruses,
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extensive database searches have recently shown that borna-
viruses, millions of years ago, integrated their genomic DNA
counterpart into the genomes of primates and some other
vertebrates [13,14]. This sort of phenomenon has been demon-
strated in vitro in some infected cell lines and also in vivo, in a
laboratory mouse [13].
However, BDV or a BDV-like agent are not only endogenized,
but also induce exogenous infections with associated diseases.
Borna disease of horses is a long-known disease in central Europe,
but is nowadays also occurring elsewhere, and occurs in several
other vertebrates, for example the sheep, rabbit, dog, cat, and cow
[1]. Instead of or in addition to an exogenous BDV infection, what
cannot be excluded is whether possible human BDV-related
symptoms [4] are linked to endogenous Borna-like sequences
(EBL). The role of EBLs in human disease is unknown, and
hypotheses exist as to both a protective role for them and a
pathogenic function [13,14].
Currently no reports exist on infection studies carried out in
wild rodents. However, numerous laboratory animals can be
experimentally BDV-infected [15]. Rats mainly develop fatal, non-
suppurative encephalitis, when infected as immunocompetent
adults, whereas neonatal infection leads to mild symptoms
including locomotor hyperactivity, learning deficits, and abnormal
social behavior, but with no evidence of an inflammatory response
[15–19]. Neonatal infection in laboratory rats leads to abundant
BDV excretion at least in urine [18,20]. The literature on BDV
infection of other laboratory rodents is less copious, but the golden
hamster and certain mouse strains establish asymptomatic
infections, whereas most mice of the MRL strain develop a fatal
encephalomyelitis [15,21,22], and neonatally infected gerbils
perish despite the lack of any pathological changes [23]. Still,
what has been learned from infection studies in laboratory rodents,
which often have altered susceptibility to infections due to deficits
perhaps in innate immunity [24,25], is not necessarily easy to
generalize to any wild rodent species.
The epidemiology of BDV is still enigmatic. Should the results
of the controversial circulatory immune complex-detecting
method be confirmed [8,10], the virus infects up to 100% of
humans [26] and horses and would spread through the close
contact of countless infected individuals. However, research
groups using several other methods suggest a much lower
prevalence [4]. Furthermore, numerous epidemiological data
point towards the existence of a wild-life reservoir [27,28]. For
instance, in horses and sheep, the infection is not easily transmitted
horizontally; BDV prevalence is higher on farms with poor rodent
control and hygiene [29]; and BDV strains cluster geographically
rather than according to species or year of isolation [30].
Furthermore, epidemics are observed at 2 to 5 year intervals
[28,29], and as for feline infections risk factors are their hunting
and a rural habitat [31]. Moreover, BDV can be transmitted
horizontally in laboratory rats via urine [20]. While these data
provide indirect evidence of a possible reservoir in small wild
mammals, natural infections have, indeed, been detected alongside
probable equine Borna disease cases in small wild mammals:
insectivores (the bicolored white-toothed shrew, Crocidura leucodon)
in Switzerland have been BDV-positive based on the demonstra-
tion of BDV RNA and antigen in tissues, and voles (root/tundra
vole, Microtus oeconomus; bank vole, Myodes glareolus) in Finland have
harbored antibodies [32–34]. The bank vole is one of the most
common rodent species in Europe [35] _ its distribution in Europe
clearly includes the areas where BDV infections in animals are
reported [27,33,36,37].
Based on the epidemiological evidence of a wild rodent reservoir
for BDV and our previous findings of BDV antibodies in bank
voles, we hypothesized that bank voles can act as a BDV reservoir
and could therefore be productively infected without overt
pathology. Furthermore, because of the recent demonstration of
integration of BDV and BDV-like DNA sequences [13,14], we
decided to test whether reverse transcription of exogenous BDV
RNA into DNA occurs in these wild mammals during infection.
We therefore infected neonate bank voles intracerebrally,
monitored the voles for 2 to 8 weeks, and subsequently assessed
the extent of BDV infection, the associated pathological changes,
and the potential generation of BDV DNA. We found support for
both hypotheses: a possible role for bank voles as a BDV reservoir
or transmitter, and, after exogenous infection, in vivo reverse
transcription of BDV RNA indicating that it represents a common
phenomenon.
Results and Discussion
BDV replicates in the bank vole brain after neonatal
intracerebral infection
In order to verify whether BDV infection can be established in
bank voles, we inoculated newborn bank voles intracerebrally (i.c.)
with 102, 103, or 104 ffu of BDV [27] or phosphate-buffered saline
(control voles) within 24 h of birth from BDV-negative dams.
Litters including the dams were housed in separate, individually
ventilated, HEPA-filtered cages, and young bank voles were
euthanized 2, 4, 6, or 8 weeks post-infection (p.i.). Their brains
were collected and examined by reverse transcriptase (RT) PCRs
for BDV nucleocapsid (N) and phosphoprotein (P) genes [33,38]
and by immunohistology for the respective antigens [39,40].
Both BDV RNA and antigen were detectable in all infected
voles, whereas controls were BDV-negative (Table 1, Table S1),
demonstrating productive infection. In one infected vole, no BDV-
N RNA was detectable despite the presence of BDV N-antigen,
which confirmed the productive infection. All other infected vole
brains tested positive for the RNA and protein of both BDV-N and
-P. Dams and controls remained negative until the end of the
study.
Intracerebral BDV inoculation leads to viral spread in the
entire brain and the peripheral nervous system
To identify the BDV target cells and viral spread, immunohis-
tology was employed using mono- and polyclonal antibodies for
BDV N [39,40] and P [40]. Viral antigen was detectable in a large
proportion of neurons in all brain areas (cortex, hippocampus,
hypothalamus, cerebellum, brain stem), and was detected both in
cell bodies and processes (Figure 1). The expression patterns for
both antigens were identical, but the nucleoprotein reaction was
generally more intense (Figure 1), as would be expected in the
acute phase of the infection when N is expressed more abundantly
than P [41]. All neuronal cell types appeared infected, but in
variable proportions. No obvious difference appeared in the
distribution and intensity of viral antigen expression at the
different time points p.i.
BDV is known to spread centrifugally via peripheral nerves in
experimentally infected rodents [42–45]. To assess whether this
also occurs in bank voles, we examined a range of tissues for the
presence of BDV antigen and observed it in axons in peripheral
nerves, for example in the mediastinum and the mesentery, in
skeletal muscle (femoral nerve), and in the urinary bladder in a
large proportion (68%) of voles and as early as 2 weeks p.i.
(Figure 2; Table S1). Neurons in autonomic ganglia (in
mediastinum, esophageal wall, urinary bladder) were also infected
(Figure 2B,C; Table S1). Interestingly, the urine of 3 voles whose
interstitial nerve fibers in the urinary bladder wall exhibited viral
Experimental BDV Infection of Bank Voles
PLoS ONE | www.plosone.org 2 August 2011 | Volume 6 | Issue 8 | e23622
Table 1. BDV antigen, RNA, and DNA in brain samples of infected and control bank voles at various time points after infection.
2 weeks p.i.a 4 weeks p.i. 6 weeks p.i. 8 weeks p.i. Total
N and P antigenb 10/10c 15/15 14/14 2/2 41/41 (100%)
N gene RNAd 10/10 14/15 14/14 2/2 40/41 (98%)
P gene RNAe 10/10 15/15 14/14 2/2 41/41 (100%)
N gene DNAd 5/10 11/15 9/14 2/2 27/41 (66%)
P gene DNAe 0/10 1/15 0/14 0/2 1/41 (2.4%)
Negative controls, antigen, RNA and DNAb,d,e 0/3 0/3 0/3 0/9 (0%)
ap.i. = post infection.
bBDV N and P antigens as detected by immunohistology [39,40].
cResults expressed as number of positive samples/number of samples studied.
dBDV N gene as detected by RT-PCR (RNA) or PCR (DNA) [33].
eBDV P gene as detected by RT qPCR (RNA) or qPCR (DNA) [47].
doi:10.1371/journal.pone.0023622.t001
Figure 1. BDV antigens expressed in neurons in all brain areas. Bank vole 1. A.–C. Demonstration of BDV N protein with monoclonal antibody
Bo-18. A. Cortex. A small proportion of neurons in the superficial granular layer (arrow) and numerous neurons in the superficial pyramidal layer
(arrowhead) express viral antigen in cell bodies (arrowhead). The fine lined staining in the remaining parenchyma represents viral antigen in cell
processes (see also B). B. Hippocampus, CA1. A few pyramidal cells (arrow) and scattered neurons in Stratum radiatum and Stratum oriens
(arrowheads) express viral antigen C. Cerebellum. Purkinje cell bodies (black arrow) and processes (black arrowhead) exhibit the most prominent
reaction. Some neurons in the granular layer (white arrow) and the molecular layer (white arrowhead) are also positive. D. Staining for BDV P protein
shows a similar expression pattern, but with generally lower intensity. Arrows and arrowheads: see C. Bars = 20 mm.
doi:10.1371/journal.pone.0023622.g001
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Figure 2. BDV antigen expressed in the peripheral nervous system. Demonstration of BDV N protein with monoclonal antibody Bo-18. A.
Bank vole 5. Section of M. quadriceps femoris (*) with embedded femoral nerve (arrows) expressing BDV antigen in axons. Bar = 20 mm. B. Bank vole 4.
Esophagus (E: epithelial layer). Between muscle layers (M) is a myenteric plexus structure with two neurons expressing BDV antigen (arrowheads). The
adjacent mediastinal nerve exhibits abundant viral antigen in axons (arrow). Bar = 20 mm. Inset: B. Bank vole 4, expressing BDV antigen in neurons of a
myenteric ganglion structure (arrow) in the urinary bladder wall. Bar = 10 mm. C. Bank vole 6. Trachea (RE: respiratory epithelium; M: muscle layer) and
adjacent mediastinal ganglion with BDV antigen in neurons (arrows). Viral antigen is also expressed in axons of nerve fibers in the tracheal wall
(arrowheads). Bar = 20 mm. D. Urinary bladder wall. Bank vole 36. BDV antigen is expressed in axons in an interstitial nerve (arrow) and in nuclei of
smooth muscle cells (arrowheads). Inset: Bank vole 6. Smooth muscle cells express BDV antigen in both nucleus and cytoplasm (arrowhead).
Bars = 10 mm. E, F. BDV antigen expression in non-neuronal cells. E. Bank vole 36. M. quadriceps femoris with BDV antigen in axons of interstitial nerve
fiber (arrowheads) and in the cytoplasm of a myofiber (arrow). Inset: Bank vole 6. Myocardium with BDV antigen in a single myofiber. Bars = 10 mm. F.
Bank vole 36. Adrenal gland. BDV antigen is expressed by several chromaffine cells in the medulla (M). C: Cortex. Bar = 10 mm.
doi:10.1371/journal.pone.0023622.g002
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antigen, tested positive for BDV RNA (Table 2). In 2 of these bank
voles, a variable number of smooth muscle cells also expressed
BDV antigen (Figure 2D; Table S1), which was seen in an
additional 2 voles that did not appear to excrete virus into their
urine at the time of euthanasia. These findings suggest that in bank
voles, BDV spreads sooner than in mice (day 120 p.i.) [45], similar
to the spread in newborn rats (day 14 p.i.) [43].
Apart from urinary bladder smooth muscle cells, other
extraneuronal cells, such as the chromaffine cells in the adrenal
medulla and myocytes in heart and skeletal muscle, occasionally
expressed BDV antigen in voles with widespread expression in the
peripheral nervous system (Figure 2E,F; Table S1), indicating
peripheral nerves as the source of infection of parenchymal cells.
All other tissues were BDV-antigen-negative. These findings are in
accordance with BDV antigen detection in extraneuronal cells in a
naturally infected horse [46], experimentally infected newborn rats
and severely immunosuppressed adult rats [43], and recently, two
naturally infected shrews [34]. Nonetheless, in all these animals
including the voles in the present study, BDV antigen expression
was mainly evident in neuronal tissues (reviewed by [1,15]).
Neonatally infected bank voles excrete BDV in urine and
feces
BDV is known to be excreted in the urine but not in feces of
neonatally infected rats [18,20,47]. Having demonstrated BDV
antigen in nerves and ganglia of urinary bladder and the
alimentary tract (esophagus), we examined the bank voles for
BDV excretion in urine and feces by RT-PCR [33,38]. Viral RNA
was detectable both in urine (6 of 36; 17%) and in feces (20 of 37;
54%) (Table 2) of infected voles, but not in controls. The urine
tested positive as early as 2 weeks p.i., but the feces were positive
from 4 weeks on except for one euthanized symptomatic vole at 3
weeks (Table S1). The proportion of PCR-positive excreta
increased with time up to week 6 p.i., most likely reflecting the
time-span for centrifugal spread via peripheral nerves. Indeed,
voles excreting BDV almost invariably expressed BDV antigen in
their peripheral nerves (Table S1) and in particular in the urinary
bladder, where interstitial nerve fibers tested positive in 60% (15 of
25) of the voles tested at weeks 4 to 8 p.i. (Table 2, Table S1).
Interestingly, BDV was detectable earlier in urine than in feces,
although it did, overall, appear more often in the latter (Table 2).
Such a difference in excretion kinetics may in part be related to an
inhibitory effect of feces on RT-PCR. Results in hantavirus-
infected bank voles (10 to 100 times fewer spiked hantavirus RNA
copies/ml detectable in feces than in urine) suggest this [48]. If so,
the fecal RNA prevalence is probably an underestimate, and
excretion might occur also at the earlier time point. However, our
results also indicate strong and long-lasting BDV excretion in
urine, since BDV RNA was found in urine at all time points p.i.
Similar to hantavirus in bank voles [48], BDV may be excreted
intermittently in urine, because not all voles exhibiting BDV
antigen in the bladder also showed BDV RNA in their urine at the
time of sampling.
Some, but not all, neonatally infected bank voles mount
an antibody response to BDV
We utilized an immunofluorescence assay (IFA) [33] to study
the antibody response of infected bank voles. BDV-specific
antibodies were not detectable at 2 weeks p.i., only at 4 weeks
p.i. and thereafter (Table S1). These results are similar to those
from other experimentally infected rodents, in which antibodies
were detectable from days 10 to 35 p.i. onwards, depending on
rodent species, strain, immune state, and viral dose [47,49–51].
Overall, antibodies were detectable in 41% (16 of 39) of the voles.
Most (59%) voles, among them some tested after 6 weeks p.i., had
no detectable antibody level. This phenomenon was once reported
in one infected laboratory rodent [20] but is common in naturally
infected animals such as cats, sheep, and horses [3,40,52]. The
Table 2. Presence of BDV in urinary bladder, urine, and feces of experimentally infected bank voles.
Infectious dose Study object 2 weeks p.i.a 4 weeks p.i. 6 weeks p.i. 8 weeks p.i. Total
102 ffu Urinary bladderb 0/2c 1/3 1/3 2/8 (25%)
Urined 2/2 1/2 0/2 3/6 (50%)
Fecesd 0/1 1/3 0/3 1/7 (14%)
103 ffu Urinary bladder 0/2 2/5 2/4 0/1 4/12 (33%)
Urine 0/2 0/5 0/6 0/1 0/14 (0%)
Feces 0/2 3/4 5/6 1/1 9/13 (69%)
104 ffu Urinary bladder 0/2 4/4 4/4 1/1 9/11 (82%)
Urine 0/4 0/6 2/5 1/1 3/16 (19%)
Feces 0/5 4/6 5/5 1/1 10/17 (59%)
All doses, total Urinary bladder 0/6 (0%) 7/12 (58%) 7/11 (64%) 1/2 (50%) 15/31 (48%)
Urine 2/8 (25%) 1/13 (7.7%) 2/13 (15%) 1/2 (50%) 6/36 (17%)
Feces 0/8 (0%) 8/13 (62%) 10/14 (71%) 2/2 (100%) 20/37 (54%)
Negative controlse Urinary bladder 0/3 0/2 0/3 0/8 (0%)
Urine 0/2 0/3 0/2 0/7 (0%)
Feces 0/3 0/2 0/3 0/8 (0%)
ap.i. = post infection.
bBDV nucleocapsid (N) and phosphoprotein (P) antigens detected in urinary bladder by immunohistology [39,40].
cResults are expressed as number of positive samples/number of samples studied (%).
dBDV N and P gene RNA detected in excreta by RT PCRs [33,47].
eNegative control voles mock-infected with phosphate-buffered saline.
doi:10.1371/journal.pone.0023622.t002
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reason for the delay in or absence of a humoral response is
unknown, but what must be considered is that our study animals
were outbred and most likely had fully functioning immune
systems – which is not necessarily the case in laboratory-bred rats
and mice [24,25]. This is supported by the fact that laboratory
mice die soon after tick-borne encephalitis virus infection [53],
whereas bank voles thrive despite infection [54].
Our data do suggest that, if based on seroprevalence,
calculation of the true BDV prevalence in bank voles and number
of voles shedding the virus would be an underestimation.
BDV infection of neonatal bank voles induces only
sporadic clinical and pathological changes
Each vole was clinically monitored on a daily and blinded basis
and closely observed in an individual cage to detect any potential
treatment-related symptoms. Then they were euthanized. The
majority (31 of 41; 76%) of those infected and all 9 control voles
remained free of clinical symptoms for the entire observation
period; the remaining 10 voles (24%), however, developed
neurobehavioral changes (Table S1). Four of these voles exhibited
severe symptoms: One circled and fell down and had to be
euthanized 3 weeks p.i., another occasionally showed tremor and
was euthanized 6 weeks p.i., the third died after one day of
locomotor hyperactivity, and the last one was first hyperactive and
later atactic, tremoric, spastic, apathic, and emaciated, with scruffy
fur (Table S1). The other 6 voles showed locomotor hyperactivity,
unpredictably leaping, even jumping out of their cages, a finding
similar to that in BDV-infected MRL/+ mice [50]. Female voles (7
of 16) were significantly more frequently affected than males (3 of
25; Mid-P exact test p = 0.0154), consistent with a study in rats
that suggested a role for sexual hormones in Borna disease
pathogenesis. However, the most relevant finding from our clinical
examination was that BDV does generally not kill bank voles, but
the infection is able to establish itself, and the virus to be shed for
several weeks _ all important prerequisites for a reservoir.
The brains of all voles were examined histologically for
pathological changes associated with BDV infection. Voles with
clinical symptoms exhibited no evidence of an inflammatory
reaction. The cerebrum, hippocampus, and brain stem were
unaltered, as was the cerebellum in most (4 of 6) cases. The vole
euthanized due to its clinical signs, however, showed reduced
number of Purkinje cells (PC). Small numbers of disseminated PCs
were undergoing necrosis or apoptosis or both, as confirmed by
immunohistology for active, cleaved caspase-3 in occasional PCs
([55]¸data not shown). This was despite the lack of apparent
differences in viral antigen expression in comparison to that of
other infected voles. In the vole that had shown an occasional
tremor, its number of PCs also appeared lower than in controls.
Seven voles, which were euthanized 4 and 6 weeks p.i., had very
mild focal leptomeningeal and occasionally adjacent parenchymal
perivascular inflammatory infiltration consisting of mononuclear
cells (macrophages, some lymphocytes) in the parietal cortex
(Table S1). This was associated neither with clinical symptoms,
morphological evidence of neuronal cell death, nor increased
neuronal BDV antigen expression. Similar mild mononuclear
infiltrations may appear in BDV-infected mice and neonatally
infected rats independent of viral distribution [15,56,57]. What
cannot be excluded is that such inflammatory infiltration was a
response to the intracerebral injection. No other organ examined
in any vole exhibited significant pathological changes.
Taking into account that the control voles remained asymp-
tomatic, one can conclude that these neurobehavioral changes in
infected voles were likely a consequence of BDV infection.
However, based on sample size, these findings are not supported
statistically (Mid-P exact, p = 0.055). Nonetheless, they are
consistent with findings in neonatally BDV-infected laboratory
mice and rats [15,50,58], which are considered to be a
consequence of neurotransmitter imbalance [59]. Indeed, BDV
seems to be able to alter and impair the functions of nerve cells
through interference with the protein kinase C –dependent
signaling by the P protein, affecting the stimulus-induced synaptic
plasticity [60,61]. Nevertheless, most voles in this study remained
asymptomatic, and those symptoms observed did not significantly
correlate with BDV infection status.
The clinical symptoms observed in the vole with evidence of PC
death were dominated by circling and falling; symptoms probably
resulting from the lack of PCs’ inhibitory effect on the vestibular
nuclei [62]. PC loss has also occurred in neonatally infected rats
[63]. These findings provide evidence of a direct effect of BDV on
PC. The precise mechanisms of PC loss are likely complex, but
apoptosis apparently contributes to it [63–65]. Unlike in rats, BDV
appeared to induce no neuronal cell death in experimentally
infected gerbils, while inducing clinical symptoms, and, contrary to
our findings, the neuronal BDV expression pattern differed
between symptomatic and healthy gerbils [23].
As intracerebral infection induced only sporadic and mild
pathological responses in our study, it can be concluded that BDV
may not be a significant pathogen for bank voles.
BDV RNA is reverse transcribed into DNA in bank voles in
vivo
Recent studies demonstrate reverse transcription of BDV-like
sequences and integration of the respective DNA into mammalian
genomes [13,14]. We were interested to know whether RNA from
exogenous and consequently replicating BDV in bank voles is
efficiently transcribed into DNA. We employed two PCRs without
the RT step to amplify BDV N and P genes from infected voles’
brain DNA [33,38].
BDV N gene DNA was present in 27 (66%), of those 41
infected, but not in the control voles, thus excluding amplification
of possible endogenous BDV-like sequences (Table 1). BDV N
DNA prevalence increased with increasing infection dose from
50% (4 of 8) to 78% (14 of 18), and was highest at 4 weeks p.i. at
73% (11 of 15; data not shown). This reverse transcription from
RNA into DNA had occurred in half (5 of 10) of those voles
studied as early as 2 weeks p.i. and was still detectable at 8 weeks
p.i. In addition to the universal finding of N DNA, BDV P gene
DNA was identifiable in one vole (Table 1, Table S1). This vole
had received the highest dose and underwent testing at 4 weeks p.i.
In addition, several other (12 of 41, 29%) infected voles showed a
borderline result in the P-qPCR (Table S1). PCR positivity was
sensitive to digestion of the template with DNAse, but not RNAse,
confirming that detection of BDV DNA sequences was due to the
presence of specific DNA and was not a result from nonspecific
RNA amplification (Figure 3, Table 3). The sequenced 258-bp
long N-amplicons from RNA RT-PCR and DNA PCR of one vole
tested 6 weeks p.i. were 100% identical, with no sequence
heterogeneity (quasispecies) observable (data not shown). These
results verify BDV N-gene DNA findings from the extensive in
silico studies [13,14] and the more restricted experiments with cell
cultures and 3 laboratory mice 30 days p.i. [13]: exogenous BDV
N RNA is indeed reverse transcribed into DNA in vivo during
infection. Furthermore, our study expands knowledge as to the
time scale of the reverse transcription and adds data on P gene
reverse transcription.
The mechanism of BDV reverse transcription in the bank vole
remains to be elucidated. How and why BDV, but not some other
RNA viruses, activates the reverse transcriptases, remains
Experimental BDV Infection of Bank Voles
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enigmatic, although BDV replicates in the nucleus. Likely
candidates for reverse-transcribing BDV genes in bank voles are
LINE-1 transposons (L1), which do exhibit reverse transcription
activity [13]. Not only the human, but also the mouse and rat
genome has included L1s ever since their common evolutionary
ancestor [66], rendering it very likely that the bank vole also has
these genes. Whatever the mechanism of reverse transcription in
the brain of a BDV-infected bank vole, no mutations were
detectable between the short BDV amplicons obtained from RNA
and DNA.
Although this reverse transcription was consistent during bank
vole BDV infection, further studies should investigate whether
these viral genes exist in episomal DNA form or are inserted into
the genome. The bank vole genome is not yet available to address
directly the question whether endogenized BDV-like elements
(EBL) exist in the bank vole genome, as demonstrated for some
other rodents such as the rat, mouse, and squirrel [13,14]. EBLs
may play a role in the epidemiology of BDV, since they may be
advantageous and enable a species to function as a reservoir.
Species showing EBL sequences (like primates, shrews, mice, and
rats) seem more resistant to severe or lethal bornavirus infection
than those with none (horse, dog, cat, and rabbit) [14]. This may
result from protection mediated by expression of indigenous BDV
N or other components.
Could the bank vole be a BDV reservoir?
The present study clearly demonstrates for the first time that
one mammal, a wild rodent species very common in endemic
BDV regions, the bank vole, can be infected with and excrete
BDV, generally without developing clinical disease or overt
pathological changes. More specifically, we were able to establish
productive infection after intracerebral viral inoculation, based on
the combined demonstration of viral RNA and antigen. That
BDV is rarely lethal in the bank vole would fit well into the picture
of a possible reservoir. Specifically, the reservoir species cannot be
too severely affected to be able to spread a pathogen; benign
behavioral alterations may even assist the spread.
The bank vole is very common in Europe [35], also throughout
the areas of BDV distribution [27,33,36,37]. Bank voles occupy
many kinds of woody habitats, but in winter may reside inside
animal sheds and homes [35]. Population densities fluctuate
strongly, in a few-year cycle [67,68]. Moreover, BDV case
numbers have fluctuated in such cycles [28,29], but any
association with bank vole population densities remains to be
shown. Interestingly, asymptomatic bank voles excrete and
transmit another pathogen, Puumala hantavirus, in saliva, urine,
and feces for at least 44 to 84 days p.i. with persistence of this virus
[48], which has some similarities to BDV excretion in our findings.
Further experimental infections could be extended to include
other inoculation routes and frequent urine, feces, and saliva
sampling to characterize in more detail the pattern of BDV
excretion, as well as to use cohousing with uninfected individuals
to study transmission. In this study, no horizontal transmission of
BDV from infected offspring to dams was detectable but cannot be
excluded: Dams remained healthy, and no viral RNA, antigen, or
antibodies could be detected at the end of the study, around 12
days after weaning and 40 days after infection of the pups.
However, rat dams, after infection of their litters and when co-
housed during the entire period, can acquire the infection and
succumb to severe Borna disease between 3 and 5 months [47],
suggesting that our observation period was too short to claim no
horizontal BDV infection of the dams.
Based on the present results and the previous demonstration of
BDV antibodies in wild-caught voles [33], a future study to
identify wild, natural BDV carriers by RT-PCR and immunohis-
tology would also be relevant.
Conclusions
Bank voles can be productively infected after intracerebral
inoculation of various doses of BDV. The infection does not
generally lead to pathological alterations and is mainly subclinical.
A minority of the infected voles produce antibodies. BDV infection
in the bank vole is primarily neurotropic, although it spreads
centrifugally from the widely infected central nervous system into
several peripheral nerves and ganglia, for instance in the urinary
bladder. Often, the virus is also excreted in urine and feces.
Furthermore, BDV RNA is commonly reverse transcribed into
DNA in bank vole brain tissue, verifying that this newly detected
phenomenon, which is necessary for genome integration of
sequences of an RNA virus, occurs readily in vivo during BDV
infection. In addition to confirming this crucial step in the
endogenization process, these data provide evidence that the bank
vole can be a potential BDV reservoir.
Table 3. PCR findings and verification of BDV DNA in four DNA-positive and one DNA-negative (italicized) bank vole.
Vole,
code
Infectious
dose, ffu
Weeks, post
infection P gene, qPCR
a, Ct values N gene, PCR
b
RNA + RT DNA RNA + RT DNA DNA + DNAse DNA + RNAse
1 103 6 23.9 45.8 + + 2 +
9 104 4 20.8 46.7 + + 2 +
23 104 5 20.4 47.5 + + 2 +
40 103 6 20.6 47.2 + + 2 +
20 103 6 18.8 No Ct + 2 2 2
aBDV P gene as detected by RT qPCR (RNA) or qPCR (DNA) [47].
bBDV N gene as detected by RT-PCR (RNA) or PCR (DNA) [33].
doi:10.1371/journal.pone.0023622.t003
Figure 3. BDV RNA and DNA present in vole brain as verified
with PCR and nuclease treatments. BDV DNA amplified by PCR
without previous nuclease treatment (lane A) and after RNAse (lane B)
but not after DNAse digestion (lane C). BDV RNA amplified with BDV RT-
PCR (lane D).
doi:10.1371/journal.pone.0023622.g003
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Materials and Methods
Ethics statement
The County Administrative Board of Southern Finland
approved the facilities and the protocol (Permit number ESLH-
2006-03286/ym-23), which followed Finnish legislation for animal
experiments (MMMa 36/2006). All efforts were made to minimize
suffering.
Animals, viruses and sampling
Thirteen serologically BDV-negative, pregnant laboratory-born
bank voles of wild-caught parents, entered a Biosafety level 3
laboratory 1 to 2 weeks before giving birth to 2 to 6 pups each.
Each litter lived, together with their dam, in an individually
ventilated, HEPA-filtered cage (Isocage Unit, Tecniplast, Italy).
We checked the function of the cage unit and the welfare of the
voles daily. In addition to the usual forage and water, the voles ate
raw potatoes to guarantee their fluid balance. The 41 newborn
voles were infected intracerebrally (i.c.) with a 25G needle with
5 ml of fourth rat passage of the BDV/He80 strain, the so-called
‘‘rat BDV’’ [27] diluted in phosphate-buffered saline (PBS) to
contain 102, 103, or 104 ffu of virus, or, as a control (9 pups), with
pure PBS. The voles were weaned at age of 4 weeks by removal of
the dams. After 2 (13 voles), 4 (17 voles), 6 (16 voles) or 8 (2 voles)
weeks post infection (p.i.), the voles were euthanized under
isoflurane anesthesia by cervical dislocation. One severely
symptomatic vole was euthanized at 3 weeks p.i., and another
died 5 weeks p.i. Voles from each litter were equally included in
groups at pre-set times. Before anesthesia, we observed the voles in
their individual cages, followed by collection of blood samples
from the retro-orbital sinus with capillary tubes under anesthesia
just before euthanasia. Subsequently, urine and the rectum with
feces (at least four times the volume of rectal tissue) and a range of
tissues were aseptically collected, including brain, salivary glands,
heart, lung and mediastinum, liver, kidney, spleen, urinary
bladder, inner genitals, and Musculus quadriceps femoris, were stored
at 280uC, or fixed in 10% buffered formalin at room temperature
for one week or both, followed by routine paraffin embedding.
Tissue homogenization and nucleic acid extraction
Brain tissue and feces (50–100 mg) were homogenized in 1 ml
of Tripure Isolation Reagent (Roche) with 5-mm glass beads
(LENZ Laborglas) and sterile sand (Merck) by 5000 rpm on the
MagNAlyser homogenizer (Roche) for 45 sec. After centrifugation
at 3000 g for 5 min, the supernatant was subjected to RNA
extraction. For 50 to 100 ml of urine, RNA was extracted with
1 ml of the Tripure reagent; for smaller available volumes of urine,
the amount was 500 ml. RNA findings were confirmed and DNA
existence studied from brain tissue samples homogenized similarly
in 1 ml of extraction buffer of the AllPrep RNA/DNA kit
(Qiagen), and further processed according to manufacturer’s
instructions.
PCRs and the verification of DNA findings
Urine and rectal/fecal RNA was reverse transcribed and the
BDV nucleocapsid protein (N) gene amplified with nested PCR as
described previously [33]. Brain RNA was processed in the same
way but with a single, outer PCR round. The BDV phosphopro-
tein (P) gene RNA was detected by real-time qPCR as described
[38]. BDV DNA was detected with the same N and P primers and
probes in the same conditions but without the reverse transcription
(RT) step. Only samples positive for both N and P RT-PCRs were
interpreted as containing BDV RNA.
Amplicons originating from both RNA and DNA of one vole
were purified with Exonuclease I and SAP enzymes (Fermentas)
and cycle sequenced for both directions with Big Dye Terminator
reagents (Applied Biosystems) in the ABI 3130xl capillary
sequencer device. The sequences were checked and analyzed
with the BioEdit program (http://www.mbio.ncsu.edu/BioEdit/
page2.html).
DNA findings were verified by nuclease digestions: Extracted
DNA was digested with DNAse for 30 min at room temperature
followed by DNAse inactivation with 10 mM EDTA at 65uC for
10 min. As a positive control, similar digestion with RNAse was
performed. Both enzymes originated from the RecoverAll kit
(Ambion).
Histology and immunohistology
Sections (3–5 mm) were prepared and stained with hematoxylin-
eosin for histological evaluation, or were subjected to immuno-
histology. Immunohistology for the demonstration of BDV
antigens was performed with the Ventana DAB biotin avidin
detection kit on the Ventana Discovery Automatic Slidestainer
(Ventana Medical Systems). The protocol included 20 min
incubation with either rabbit polyclonal anti-BDV-nucleocapsid
protein (N) 1:5000 [40], mouse monoclonal anti-N antibody Bo-18
1:100 [39], or polyclonal anti-BDV-phosphoprotein (P) 1:20 000
[40]. BDV-infected horse brain tissue served as a positive control
for all three anti-BDV antibodies. Consecutive sections incubated
with the pre-immune serum instead of the anti-BDV antisera
served as negative controls. Cleaved caspase-3 expression was
demonstrated according to an earlier protocol [55].
Serology
BDV-specific antibodies were sought from a 1:10 PBS dilution
of the whole blood samples with an immunofluorescence assay
using BDV He/80 as the antigen in persistently infected C6 cells
as described [33].
Statistical methods
All the statistics were performed with an epidemiologic
calculator in the Internet [69]. As recommended for small data
sets [70], we employed the Mid-P exact test for analyzing
significance.
Supporting Information
Table S1 Individual information of experimentally
BDV-infected bank voles.
(XLS)
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